1. Home
  2. ETW vs MDXG Comparison

ETW vs MDXG Comparison

Compare ETW & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eaton Vance Corporation Eaton Vance Tax-Managed Global Buy-Write Opportunites Fund of Beneficial Interest

ETW

Eaton Vance Corporation Eaton Vance Tax-Managed Global Buy-Write Opportunites Fund of Beneficial Interest

HOLD

Current Price

$9.00

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo MiMedx Group Inc

MDXG

MiMedx Group Inc

HOLD

Current Price

$4.24

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ETW
MDXG
Founded
N/A
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2005
2007

Fundamental Metrics

Financial Performance
Metric
ETW
MDXG
Price
$9.00
$4.24
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$10.00
AVG Volume (30 Days)
337.3K
752.4K
Earning Date
01-01-0001
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.29
EPS
N/A
0.32
Revenue
N/A
$418,630,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$13.14
P/E Ratio
N/A
$13.23
Revenue Growth
N/A
19.99
52 Week Low
$6.93
$4.23
52 Week High
$9.60
$8.13

Technical Indicators

Market Signals
Indicator
ETW
MDXG
Relative Strength Index (RSI) 37.24 24.84
Support Level $8.87 N/A
Resistance Level $9.13 $7.41
Average True Range (ATR) 0.10 0.17
MACD -0.03 -0.02
Stochastic Oscillator 10.62 1.31

Price Performance

Historical Comparison
ETW
MDXG

About ETW Eaton Vance Corporation Eaton Vance Tax-Managed Global Buy-Write Opportunites Fund of Beneficial Interest

Eaton Vance Tax-mangd Glo Buy-write Oppo is a United States-based diversified, closed-end management investment company. The primary investment objective of the company is to provide current income and gains. The secondary objective of the fund is capital appreciation. The fund invests in a diversified portfolio of common stocks and writes call options on one or more U.S. indices on a substantial portion of the value of its common stock portfolio to generate current earnings from the option premium. Its portfolio of investments consists of capital markets, chemicals, banks, biotechnology, media, and other sectors.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: